Mangoceuticals, Inc. (MGRX)
NASDAQ: MGRX · Real-Time Price · USD
1.588
+0.048 (3.12%)
Jul 9, 2025, 9:46 AM - Market open

Mangoceuticals Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021
Period Ending
Jul '25 Dec '24 Dec '23 Dec '22 Dec '21
1866--
Market Cap Growth
144.58%6.40%---
Enterprise Value
1865--
Last Close Price
1.542.424.15--
PS Ratio
8.2410.077.96--
PB Ratio
0.540.457.52--
P/TBV Ratio
--7.52--
EV/Sales Ratio
34.6910.386.47--
Debt / Equity Ratio
0.000.020.170.57-2.35
Asset Turnover
0.050.080.710.02-
Quick Ratio
0.050.043.502.620.57
Current Ratio
0.120.053.962.670.57
Return on Equity (ROE)
-115.89%-118.31%-1326.69%-669.02%-
Return on Assets (ROA)
-53.55%-62.72%-494.04%-242.68%-
Return on Capital (ROIC)
-60.45%-68.38%-542.58%-251.60%-
Earnings Yield
-67.85%-140.45%-158.13%--
FCF Yield
-34.61%-78.46%-120.17%--
Buyback Yield / Dilution
-113.52%-84.23%-49.22%-34.98%-
Updated Mar 20, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q